Patients like me shouldn’t have to fear for their health just because they can’t afford their medications.
Campaign Relaunches in Light of Recent Setbacks For Administration Blueprint
Americans wanted to list drug price ads on TV. Big Pharma and a federal judge said no.
I just want to be able to enjoy my time and not have trouble breathing or managing my blood sugar.
"More than 3,400 drugs have boosted their prices in the first six months of 2019, an increase of 17% in the number of drug hikes from a year earlier."
Grandmother living with diabetes, asthma to tell committee: “Drugs don’t work if people can’t afford them”
I urge the California legislature to look at my story and see that Californians like me are suffering under the high cost of medication.
Sneaky pharma tactics are keeping lifesaving generic drugs out of reach for patients who need them most.
As a community member, I share my story with you all today to show how drug pricing is a public health issue, and I ask that my representatives take a stand to lower drug prices today.
If drug corporations want to gouge patients, the public deserves to know exactly why.
Medications are simply too expensive, and patients deserve to be able to live without having to worry about spending everything in their bank accounts.
This is a victory for Maine patients and taxpayers who are fed up with unrestrained drug prices.
So many bipartisan drug pricing proposals, so little time.
Don’t be fooled by Big Pharma’s spin. There is no evidence the proposed Part B changes would impact patient access to drugs.
Patients like me cannot live with these prices, and we need lower price tags at the pharmacy counter now.
When you’re on a long list of medications, even smaller copays add up.
The US pays two to three times more than other developed nations for prescription drugs.
I shouldn’t have to pay $100 just to feel normal and find relief.
After Mainers speak out, slate of drug pricing reforms gains momentum.
The DOJ wants a jury trial for Mallinckrodt, the company at the heart of a 97,000 percent price spike for a gel mainly used to treat infant seizures.